What is Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s (603896.SS) StockRank?

MoatMap's StockRank for Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) is 27/100, with a Sell signal. This is a composite score combining Quality (52), Value (33), and Momentum (34) factor ranks across MoatMap's 19,000+ stock universe.

Does Zhejiang Shouxiangu Pharmaceutical Co., Ltd. have an economic moat?

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Zhejiang Shouxiangu Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Zhejiang Shouxiangu Pharmaceutical Co., Ltd. in?

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

603896.SS

SELLREMOVE

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. · Healthcare · China · $452M · Avg Vol: $5M/d

StockRank

P/E (TTM)

—

ROE

-0.5%

D/E

0.2x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Zhejiang Shouxiangu Pharmaceutical produces traditional Chinese medicine. It lacks any connection to our high-conviction macro themes and does not possess the global scalability or reinvestment runway of a true compounder.

COMPANY DESCRIPTION

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. cultivates, processes, and sells traditional Chinese medicinal herbs, specializing in organic Ganoderma lucidum (Lingzhi) and Dendrobium officinale. The company operates a vertically integrated 'seed-to-product' business model with proprietary breeding technology and organic certifications. It is a premium niche player in the high-end traditional Chinese medicine and health supplement market.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	123M	116M	104M	95M	-8.3%
EPS	0.21	0.19	0.13	0.01	-60.2%
Shares	197M	202M	198M	198M	+0.5%
Debt	104M	111M	87M	91M	-4.5%
Equity	282M	321M	339M	334M	5.8%
Op CF	50M	47M	32M	34M	-12.6%
Inv CF	-13M	-192M	-35M	-42M	—
Fin CF	50M	43M	-36M	-6M	—

PRICE (1M)-10.3%

SMA 50SMA 200

$2.32

RSI (14)

47.5

52W High

$3.47

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

4.6%56.0

ROE

-0.5%44.4

GP/Assets

14.9%34.8

Op. Margin

18.7%80.5

FCF/Assets

-0.8%48.0

Piotroski

—55.8

Int. Cover

5.2x55.1

D/E Ratio

0.25x47.5

Current Ratio

3.13x54.9

Value

P/E (TTM)

—N/A

EV/EBITDA

19.1x20.1

P/FCF

—N/A

P/B

1.4x70.1

P/S

5.0x41.8

Div Yield

—N/A

Momentum

52W High %

67%51.2

RS 6M

-30%41.2

SMA 50/200

0.87x25.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-51%10.2

FUNDAMENTALS

Market Cap

$452M

P/E (Forward)

10.1x

Gross Margin

77.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 603896.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
603896.SS	Zhejiang Shouxiangu Pharmaceutical Co., Ltd.(you)	$452M	27	SELL
688687.SS	Beijing Kawin Technology Share-Holding Co., Ltd.	$431M	24	SELL
688075.SS	Assure Tech (Hangzhou) Co., Ltd.	$643M	27	SELL
6660.HK	AIM Vaccine Co., Ltd.	$368M	20	SELL
688399.SS	Jiangsu Bioperfectus Technologies Co., Ltd.	$658M	34	SELL
2197.HK	Clover Biopharmaceuticals, Ltd.	$323M	19	STRONG SELL
1167.HK	Jacobio Pharmaceuticals Group Co., Ltd.	$490M	12	STRONG SELL
688488.SS	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	$965M	28	SELL
1477.HK	Ocumension Therapeutics	$636M	37	HOLD
688302.SS	Hinova Pharmaceuticals Inc.	$582M	14	STRONG SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.0%

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) — Stock Score Summary

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) has a MoatMap StockRank of 27/100 based on Quality (52/100), Value (33/100), and Momentum (34/100) factor scores. The current signal is SELL. Zhejiang Shouxiangu Pharmaceutical produces traditional Chinese medicine. It lacks any connection to our high-conviction macro themes and does not possess the global scalability or reinvestment runway of a true compounder.

Key Financial Metrics

Price	$2.32
Market Cap	$452M
P/E (Forward)	10.08
Price/Book	1.35
Return on Equity	-0.5%
Return on Invested Capital	4.6%
Debt/Equity	24.64
Gross Margin	77.8%
Operating Margin	18.7%
Revenue Growth	-8.5%
Free Cash Flow	$-537K

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Shouxiangu Pharmaceutical Co., Ltd.’s (603896.SS) StockRank?: MoatMap’s StockRank for Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) is 27/100, with a Sell signal. It is a composite of Quality (52), Value (33), and Momentum (34) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang Shouxiangu Pharmaceutical Co., Ltd. have an economic moat?: Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Shouxiangu Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Shouxiangu Pharmaceutical Co., Ltd. in?: Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).